Suboptimal cardiovascular risk factor identification and management in patients with rheumatoid arthritis: a cohort

Insights

Primary care physicians manage cardiovascular risk factors more often than rheumatologists in rheumatoid arthritis patients. However, PCPs manage these factors less frequently in RA patients compared to those with diabetes or the general population.

Area of Science:

  • Cardiology
  • Rheumatology
  • Primary Care Medicine

Background:

  • Rheumatoid arthritis (RA) patients face accelerated cardiovascular (CV) disease, leading to increased mortality comparable to type 2 diabetes mellitus (DM).
  • Traditional cardiovascular risk factors (CRFs) contribute to this enhanced CV risk in RA.
  • Understanding CRF identification and management patterns is crucial for improving outcomes.

Purpose of the Study:

  • To compare the identification and management of CRFs by rheumatologists versus primary care physicians (PCPs) in RA patients.
  • To compare CRF management by PCPs across RA, DM, and general population (GP) cohorts.

Main Methods:

  • Retrospective cohort study design.
  • Comparison of age/gender/ethnicity-matched patients (n=251 per group) across RA, DM, and GP cohorts.
  • Review of electronic patient records over a 12-month period (June 2007-April 2011) to assess CRF identification and management.

Main Results:

  • PCPs managed obesity, blood pressure (BP), and lipids significantly more often than rheumatologists in RA patients.
  • PCPs demonstrated higher management rates for obesity, BP, and lipids in DM patients compared to RA and GP groups.
  • Weight management for elevated BMI was highest in DM (68%), followed by GP (46%), and lowest in RA (31%) patients.

Conclusions:

  • Rheumatologists identify and manage CRFs less frequently than PCPs.
  • PCPs manage CRFs less frequently in RA patients compared to DM and GP cohorts.
  • Aggressive management of CRFs is essential for RA patients due to their elevated CV risk.
Abstract

Related Concept Videos

Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...